[1]
|
Wein, A.N., Stockhausen, A.T., Hardcastle, K.I., Saadein, M.R., Peng, S., Wang, D. and Eichler, J.F. (2011) Tumor cytotoxicity of 5,6-dimethyl-1,10-phenanthroline and its corresponding gold (III) complex. Journal of Inorganic Biochemistry, 105, 663-668.
doi:10.1016/j.jinorgbio.2011.01.006
|
[2]
|
Sun, R. and Che, C. (2009) The anti-cancer properties of gold (III) compounds with dianionic porphyrin and tetradentate ligands. Coordination Chemistry Reviews, 253, 1682-1691.
doi:10.1016/j.ccr.2009.02.017
|
[3]
|
Messori, L., Abbate, F., Marcon, G., Orioli, P., Fontani, M., Mini, E., Mazzei, T., Carotti, S., O’Connell, T. and Zanello, P. (2000) Gold (III) complexes as potential antitumor agents: Solution chemistry and cytotoxic properties of some selected gold (III) compounds. Journal of Medicinal Chemistry, 43, 3541-3548.
doi:10.1021/jm990492u
|
[4]
|
Cinellu, M.A., Maiore, L., Manassero, M., Casini, A., Arca, M., Fiebig, H.-H., Kelter, G., Michelucci, E., Pieraccini, G., Gabbiani, C. and Messori, L. (2010) [Au2 (phen2Me)2(μ-O)2](PF6)2, a novel dinuclear gold (III) complex showing excellent antiproliferative properties. ACS Medicinal Chemistry Letters, 1, 336-339.
|
[5]
|
Hudson, Z.D., Sanghvi, C.D., Rhine, M.A., Ng, J.J., Bunge, S.D., Hardcastle, K.I., Macbeth, C. and Eichler, J.F. (2009) Synthesis and characterization of gold (III) complexes possessing 2,9-dialkylphenanthroline ligands: to bind or not to bind? Dalton Transactions, 28, 7473-7480. doi:10.1039/b823215f
|
[6]
|
Richardson D.R., Tran, E.H. and Ponka, P. (1998) The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. Blood, 86, 4295-4306.
|
[7]
|
Satterfield, M. and Brodbelt, J.S. (2001) Relative binding energies of gas-phase pyridyl ligand/metal complexes by energy-variable collisionally activated dissociation in a quadrupole ion trap. Inorganic Chemistry, 40, 5393-5400.
doi:10.1021/ic010356r
|
[8]
|
Pallenberg, A. J., Koenig, K. S. and Barnhart, D. M., (1995) Synthesis and characterization of some copper (I) phenanthroline complexes. Inorganic Chemistry, 34, 2833-2840. doi:10.1021/ic00115a009
|
[9]
|
Kulkarni, P., Padhye, S. and Sinn, E. (1998) Communication:: The first well characterized Fe (phen) Cl3 complex: structure of aquo mono(1,10-phenanthroline) iron (III) trichloride: [Fe (phen) Cl3 (H2O)]. Polyhedron, 17, 2623-2626. doi:10.1016/S0277-5387(97)00515-9
|
[10]
|
Hara, Y. and Akiyama, M. (2001) An iron reservoir model based on ferrichrome:? Iron (III)-binding and metal (III)-exchange properties of tripodal monotopic and ditopic hydroxamate ligands with an l-alanyl-l-alanyl-n-hydroxy-β-alanyl sequence. Journal of the American Chemical Society, 123, 7247-7256.
doi:10.1021/ja003251g
|
[11]
|
Khavasi, H.R., Amani and V., Safari, N. (2008) (2,2’-Biquinoline-2N,N’)dichloridoiron(II). Zeitschrift für Kristallographie—New Crystal Structures, 223, 41-42.
|
[12]
|
Eckenhoff, W.T., Biernesser, A.B. and Pintauer, T. (2012) Structural characterization and investigation of iron (III) complexes with nitrogen and phosphorus based ligands in atom transfer radical addition (ATRA). Inorganica Chimica Acta, 382, 84-95. doi:10.1016/j.ica.2011.10.016
|
[13]
|
Amani, V., Nasser, S., Khavasi, H.R. and Mirzaei, P. (2007) Iron (III) mixed-ligand complexes: Synthesis, characterization and crystal structure determination of iron (III) hetero-ligand complexes containing 1,10-phenanthroline, 2,2’-bipyridine, chloride and dimethyl sulfoxide, [Fe(phen)Cl3(DMSO)] and [Fe(bipy)Cl3(DMSO)]. Polyhedron, 26, 4908-4914.
doi:10.1016/j.poly.2007.06.038
|
[14]
|
Gomer, R. and Inghram, M.G. (1955) Applications of field ionization to mass spectrometry. Journal of the American Chemical Society, 77, 500.
doi:10.1021/ja01607a096
|